TITLE:
Evaluation of Viral Hepatitis B Treatment in Pointe-Noire in 2016
AUTHORS:
F. Bossali, G. Ndziessi, C. L. Ahoui-Apendi, G. Deby, M. J. F. Mimiesse, J. W. Ombila, B. I. Atipo-Ibara, J. R. Ibara
KEYWORDS:
Access, Congo, Hepatitis B, Pointe-Noire, Treatment
JOURNAL NAME:
International Journal of Clinical Medicine,
Vol.9 No.6,
June
13,
2018
ABSTRACT: Prevalence of hepatitis B in Pointe-Noire is 23%. The objective of this study was to evaluate the level of therapeutic management of patients with hepatitis B in Pointe-Noire. Methods: A retrospective, cross-sectional, descriptive and analytical study. Results: 302 patients included: 217 (72%) men and 85 (28%) women of median age 40 years. The viral load was measured in 140 (46%) patients and in 162 (54%), the viral load was not measured. Their distribution according to the viremia was as follows: 0 - 1 log = 1 (0.7%) patients; 1.5 to 2 log = 23 (16%) patients; 2.5 to 3 log = 49 (35%) patients; >3log = 55 (39%) patients. Of the 302 patients included, 36 (11%) patients were treated with antivirals and 253 (83%) patients were not. Conclusion: The number of patients treated for chronic viral hepatitis B was low. Our results show interest for improved preventive and curative management of hepatitis B in Congo in order to reduce the existing high prevalence.